Trial Profile

A Clinical Pharmacological Study to Evaluate the Effects of Iron Supplements on the Pharmacokinetics of MT-6548 in Healthy Male Volunteers

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 10 Apr 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Vadadustat (Primary) ; Ferric citrate; Ferrous sulfate; Sodium ferrous citrate; Sucroferric oxyhydroxide
Indications Anaemia; Renal failure; SARS-CoV-2 acute respiratory disease
Focus Pharmacokinetics; Registrational
Sponsors Mitsubishi Tanabe Pharma Corporation

Most Recent Events

09 Sep 2021 Results published in the Clinical Therapeutics
24 Oct 2018 Status changed from recruiting to completed.
12 Sep 2018 Status changed from not yet recruiting to recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com